September 30, 2026
All resources
Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
Filter by
October 28, 2025
October 28, 2025
2025 Cost drivers report
The private drug insurance market in Canada saw a 7.3% total cost growth in 2023-2024, primarily driven by increased utilization which accounted for 60% of total cost growth. The number of claimants rose by 3.5%, with claimants making
0.9% more claims.
September 22, 2025
May 06, 2025
May 06, 2025
Canadian drug access pathway
The process for Canadians to access new medicines is extremely complex and involves several different federal, provincial, and territorial agencies. It takes two years following approval (736 days) for Canadian patients to get access to a drug in the public plan, whereas those in the private plan get access to a drug in less than one year (226 days).
November 04, 2024
November 04, 2024
November 04, 2024
Issues and opportunities to modernize private drug plan sustainability 2024
Available in English only
October 19, 2023
October 19, 2023
Cost drivers report 2023
Annual cost growth in Canada’s private drug benefit market is driven by increased utilization and chronic disease drugs, with an increase in claimants post‑pandemic.
Read the full report.
September 15, 2023
September 15, 2023
Cost of a private drug plan claim
IMC contracted Reformulary Group to analyze the cost of a private plan prescription drug claim in Canada, and separately in Quebec. This report summarizes that analysis.
November 25, 2022
August 01, 2021
August 01, 2021
Cost drivers: Analysis of private drug plans in Canada 2021
The 2021 Cost Drivers report highlights the consistent annual cost growth in the Canadian private drug benefits market and outlines factors that contribute to price increases.
June 30, 2020
June 30, 2020
How would a single-payer publicly funded national pharmacare program affect the quality of access to medicines for Canadian patients?
Canada’s dual-payer pharmacare program works for most Canadians. But gaps need to be filled to ensure all Canadians have access to the medicines they need, regardless of income, age, sex or postal code.
August 09, 2018
